Archangels - Making The Future

Contact

John Waddell
Chief Executive
Archangel Informal Investments Limited
20 Rutland Square
Edinburgh
EH1 2BB

Tel: 0131 221 9876
Fax: 0131 229 1956
Email: john@archangelsonline.com

Alternatively you can use the enquiry form below to contact us.

Fields marked with * are required
Email Format:*     (what's this?)

  Send

Latest News

Touch Bionics unveils the new i-LIMB Pulse

05 May 2010
Touch Bionics today announced the launch of the i-LIMB Pulse, an all-new version of the revolutionary i-LIMB Hand, the wordl's first commercially available bionic hand. The i-LIMB Pulse is a significant advance for the i-LIMB product line, with a host of enhancements, including pulsing grip strength, software-enabled grip patterns and robust aluminium features for improved strength.

Touch Bionics wins prestigious Queen's Award for innovation

21 Apr 2010
Touch Bionics, developer of advanced upper-limb bionic technologies, today announced it is a winner of the prestigious Queen's Awards for Enterprise with an award in the Innovation category for 2010. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance.

Bloxx Delivers Web Filtering Excellence at Wellingborough School

21 Apr 2010
School has immediate access to safe internet surfing with Bloxx Web Filtering. Bloxx today announced that Wellingborough School is providing safe Internet access for around 900 users and achieving superior anonymous proxy detection by using Bloxx's real time Web filtering, powered by its patented Tru-View Technology.

Bloxx helps Yorkshire Building Society keep staff safe online

15 Apr 2010
Bloxx the innovator in Web content filtering, announced on 15th April that Yorkshire Building Society is using Bloxx Web filtering to monitor and report on the Web browsing activity of over 2,000 staff, delivering superior protection from imappropriate or productivity impacting content and minimising network security risks.

New "Penicillin" for the 21st Century

01 Apr 2010
Today MGB Biopharma Limited, a late preclinical stage biopharmaceutical company, has commenced operations in Glasgow, UK to develop and commercialise a new class of antibacterial product: DNA Minor Groove Binders.